HEALTHJul 24 · 22:52 UTCVIRGINIA MERCURYKelcie Moseley-Morris

Federal judge in Virginia says certain abortion drug restrictions are unlawful

A federal judge in Virginia ruled that the FDA's 2023 restrictions on mifepristone, including special certification for pharmacies and risk acknowledgment forms, are unlawful and must be reviewed. The lawsuit, filed by providers in Kansas, Montana, and Virginia, argues the restrictions are excessive and inconsistent with legal requirements.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

U.S. Food and Drug AdministrationorganizationmifepristonetopicWhole Woman’s Health AllianceorganizationAmy Hagstrom MillerpersonRobert BalloupersonKansasplaceMontanaplaceVirginiaplace

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHJul 24 · 21:19 UTC
Federal judge says certain abortion drug restrictions are unlawful
HEALTHJul 24 · 22:00 UTC
Judge rules FDA restrictions on mifepristone are arbitrary and capricious
HEALTHMay 2 · 02:22 UTC
US court limits mail-order access to abortion pill mifepristone
HEALTHMay 1 · 22:40 UTC
Court restricts abortion access across the US by blocking the mailing of mifepristone
HEALTHMay 1 · 23:29 UTC
US court limits mail-order access to abortion pill mifepristone